Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in Infants

Abstract
The RTS,S/AS malaria vaccine is being developed for delivery through the World Health Organization's Expanded Program on Immunization (EPI). We assessed the feasibility of integrating RTS,S/AS02D into a standard EPI schedule for infants.

This publication has 10 references indexed in Scilit: